Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Neither 25-hydroxyvitamin D nor PTH was associated with osteoporosis when added to the model.Co-occurrence of osteoporosis and sarcopenia versus chance expectation, with raw 2×2 counts, by sarcopenia definitionSarcopenia definitionOP+/Sarc+; OP+/Sarc-; OP-/Sarc+; OP-/Sarc-Observed vs expected, %OR (95% CI)Fisher pConfirmed sarcopenia, ALM/height21; 110; 7; 5090.16 vs 0.230.66 (0.08 to 5.43)1.00Confirmed sarcopenia, absolute ALM4; 107; 12; 5040.64 vs 0.451.57 (0.50 to 4.96)0.50Confirmed sarcopenia, FNIH ALM/BMI3; 108; 23; 4930.48 vs 0.730.60 (0.18 to 2.02)0.60Probable sarcopenia (low grip)13; 98; 67; 4492.07 vs 2.260.89 (0.47 to 1.67)0.88OP, osteoporosis; Sarc, sarcopenia.

Source: Variables Associated with Osteoporosis. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional analysis was based on a community screening study of older adults in the Vojvodina region of Serbia, conducted at the University Clinical Centre of Vojvodina in Novi Sad.

Source: Methods.

Participants were community-dwelling and aged 65 years and over.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Osteosarcopenia: More Than the Sum of Its Parts? A Community-Based Study Across Sarcopenia Definitions

Cross-sectional study · Calcified Tissue International · 2026

Original publication title

Osteosarcopenia: More Than the Sum of Its Parts? A Community-Based Study Across Sarcopenia Definitions

Radmila Matijevic; Milan Tosic; Filip Lazetic; Nikola Vukosav; Milan Majkic; Branko Baljak; Dora Selesi

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is described as a geriatric syndrome arising from shared determinants of muscle and bone. We asked how far the prevalence of sarcopenia and osteosarcopenia depends on the definition of low muscle mass, whether osteoporosis and sarcopenia co-occur more often than expected under statistical independence, and whether the muscle: bone relationship is expressed in areal bone mineral density (BMD) or in femoral geometry. Cross-sectional study of 649 community-dwelling adults aged 65 years and over (72% women; mean age 71.5 years; mean body mass index (BMI) 29.6 kg/m2) assessed with dual-energy X-ray absorptiometry (GE Lunar iDXA), grip dynamometry (Jamar Hydraulic Hand Dynamometer) and the Short Physical Performance Battery.

Osteoporosis followed World Health Organization criteria. Sarcopenia was classified according to EWGSOP2, and low muscle mass was defined three ways (appendicular lean mass (ALM)/height2; absolute ALM; and the Foundation for the National Institutes of Health (FNIH) ALM/BMI index). Observed co-occurrence was compared with the value expected under independence (Fisher exact test, odds ratios (OR) with 95% confidence intervals (CI)); for the best-powered analysis the two one-sided tests (TOST) equivalence procedure using pragmatic equivalence bounds of OR 0.5 to 2.0. Hip structural analysis provided section modulus and cross-sectional area.

Low muscle mass ranged from 3.7 to 15.7%, and confirmed sarcopenia from 1.4 to 4.2%, according to the metric. Osteoporosis prevalence was 17.6% (95% CI 14.9 to 20.8). Under none of the sarcopenia definitions was there statistically significant evidence of excess co-occurrence (Fisher p = 0.50 to 1.00), although observed overlap under the absolute-ALM definition was slightly above the independence expectation. For probable sarcopenia (low grip strength), the best-powered comparison, the OR was 0.89 (95% CI 0.47 to 1.67) and equivalence within broad OR bounds of 0.5 to 2.0 was supported (90% CI 0.52 to 1.51; TOST p = 0.037); equivalence was not supported under narrower bounds.

Appendicular lean mass was not associated with areal BMD after adjustment for body size (femoral neck standardised β = 0.03, 95% CI − 0.18 to 0.24) but was associated with femoral section modulus substantially more strongly in men than women (globally standardised interaction Δβ = 0.30, 95% CI 0.15 to 0.44, p < 0.001). In this community sample, there was no statistically significant evidence that osteoporosis and sarcopenia co-occurred more often than expected under statistical independence, across several sarcopenia definitions, although estimates for confirmed sarcopenia were imprecise.

The muscle-bone association was more apparent for femoral geometry than areal BMD and was seen predominantly in men. These findings do not support assuming that low bone mass and low muscle mass identify the same individuals, but they concern statistical co-occurrence and do not establish biological independence.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s00223-026-01611-w.

Authors’ abstract

Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is described as a geriatric syndrome arising from shared determinants of muscle and bone. We asked how far the prevalence of sarcopenia and osteosarcopenia depends on the definition of low muscle mass, whether osteoporosis and sarcopenia co-occur more often than expected under statistical independence, and whether the muscle: bone relationship is expressed in areal bone mineral density (BMD) or in femoral geometry. Cross-sectional study of 649 community-dwelling adults aged 65 years and over (72% women; mean age 71.5 years; mean body mass index (BMI) 29.6 kg/m2) assessed with dual-energy X-ray absorptiometry (GE Lunar iDXA), grip dynamometry (Jamar Hydraulic Hand Dynamometer) and the Short Physical Performance Battery.

Osteoporosis followed World Health Organization criteria. Sarcopenia was classified according to EWGSOP2, and low muscle mass was defined three ways (appendicular lean mass (ALM)/height2; absolute ALM; and the Foundation for the National Institutes of Health (FNIH) ALM/BMI index). Observed co-occurrence was compared with the value expected under independence (Fisher exact test, odds ratios (OR) with 95% confidence intervals (CI)); for the best-powered analysis the two one-sided tests (TOST) equivalence procedure using pragmatic equivalence bounds of OR 0.5 to 2.0. Hip structural analysis provided section modulus and cross-sectional area.

Low muscle mass ranged from 3.7 to 15.7%, and confirmed sarcopenia from 1.4 to 4.2%, according to the metric. Osteoporosis prevalence was 17.6% (95% CI 14.9 to 20.8). Under none of the sarcopenia definitions was there statistically significant evidence of excess co-occurrence (Fisher p = 0.50 to 1.00), although observed overlap under the absolute-ALM definition was slightly above the independence expectation. For probable sarcopenia (low grip strength), the best-powered comparison, the OR was 0.89 (95% CI 0.47 to 1.67) and equivalence within broad OR bounds of 0.5 to 2.0 was supported (90% CI 0.52 to 1.51; TOST p = 0.037); equivalence was not supported under narrower bounds.

Appendicular lean mass was not associated with areal BMD after adjustment for body size (femoral neck standardised β = 0.03, 95% CI − 0.18 to 0.24) but was associated with femoral section modulus substantially more strongly in men than women (globally standardised interaction Δβ = 0.30, 95% CI 0.15 to 0.44, p < 0.001). In this community sample, there was no statistically significant evidence that osteoporosis and sarcopenia co-occurred more often than expected under statistical independence, across several sarcopenia definitions, although estimates for confirmed sarcopenia were imprecise.

The muscle-bone association was more apparent for femoral geometry than areal BMD and was seen predominantly in men. These findings do not support assuming that low bone mass and low muscle mass identify the same individuals, but they concern statistical co-occurrence and do not establish biological independence.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s00223-026-01611-w.

Publication and source details

Original title: Osteosarcopenia: More Than the Sum of Its Parts? A Community-Based Study Across Sarcopenia Definitions

Radmila Matijevic; Milan Tosic; Filip Lazetic; Nikola Vukosav; Milan Majkic; Branko Baljak; Dora Selesi

Calcified Tissue International · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Secretary of Health of Autonomous Region Vojvodina, SerbiaSecretary of Health of Autonomous Region Vojvodina, Serbiahttp://dx.doi.org/10.13039/501100004564Ministarstvo Prosvete, Nauke i Tehnološkog RazvojaMinistarstvo Prosvete, Nauke i Tehnološkog Razvoja

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:36:58.133280+00:00

DOI: 10.1007/s00223-026-01611-w · PMC13627189